These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 39390498

  • 1. Development and feasibility testing of a time-restricted eating intervention for women living with overweight/obesity and HIV in a resource-limited setting of South Africa.
    Hoosen F, Pico ML, Goedecke JH, Dave JA, Quist JS, Færch K, Grunnet LG, de Villiers A, Aagaard-Hansen J, Mendham AE.
    BMC Public Health; 2024 Oct 10; 24(1):2768. PubMed ID: 39390498
    [Abstract] [Full Text] [Related]

  • 2. Feasibility Testing of the Health4LIFE Weight Loss Intervention for Primary School Educators Living with Overweight/Obesity Employed at Public Schools in Low-Income Settings in Cape Town and South Africa: A Mixed Methods Study.
    Hoosen F, Faber M, Nel JH, Steyn NP, Senekal M.
    Nutrients; 2024 Sep 11; 16(18):. PubMed ID: 39339661
    [Abstract] [Full Text] [Related]

  • 3. Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda.
    Alhassan Y, Twimukye A, Malaba T, Orrell C, Myer L, Waitt C, Lamorde M, Kambugu A, Reynolds H, Khoo S, Taegtmeyer M.
    BMC Public Health; 2020 Dec 07; 20(1):1883. PubMed ID: 33287795
    [Abstract] [Full Text] [Related]

  • 4. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.
    Dugdale CM, Ciaranello AL, Bekker LG, Stern ME, Myer L, Wood R, Sax PE, Abrams EJ, Freedberg KA, Walensky RP.
    Ann Intern Med; 2019 May 07; 170(9):614-625. PubMed ID: 30934067
    [Abstract] [Full Text] [Related]

  • 5. Time-Restricted Eating as a Nutrition Strategy for Individuals with Type 2 Diabetes: A Feasibility Study.
    Parr EB, Devlin BL, Lim KHC, Moresi LNZ, Geils C, Brennan L, Hawley JA.
    Nutrients; 2020 Oct 22; 12(11):. PubMed ID: 33105701
    [Abstract] [Full Text] [Related]

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 7. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol.
    Abrams EJ, Jao J, Madlala HP, Zerbe A, Catalano P, Gerschenson M, Goedecke JH, Gomba Y, Josefson J, Kurland IJ, Legbedze J, McComsey GA, Matyesini S, Mukonda E, Robinson D, Myer L.
    PLoS One; 2024 Feb 01; 19(8):e0307296. PubMed ID: 39159183
    [Abstract] [Full Text] [Related]

  • 8. A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults.
    Simpson SA, McNamara R, Shaw C, Kelson M, Moriarty Y, Randell E, Cohen D, Alam MF, Copeland L, Duncan D, Espinasse A, Gillespie D, Hill A, Owen-Jones E, Tapper K, Townson J, Williams S, Hood K.
    Health Technol Assess; 2015 Jul 01; 19(50):v-vi, xix-xxv, 1-378. PubMed ID: 26168409
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda.
    Nakatudde I, Katana E, Agnes Odongpiny EL, Nalugga EA, Castelnuovo B, Fowler MG, Musoke P.
    AIDS Res Ther; 2024 Apr 18; 21(1):23. PubMed ID: 38637785
    [Abstract] [Full Text] [Related]

  • 10. Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.
    Quist JS, Jensen MM, Clemmensen KKB, Pedersen H, Bjerre N, Størling J, Blond MB, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Færch K.
    BMJ Open; 2020 Aug 26; 10(8):e037166. PubMed ID: 32847912
    [Abstract] [Full Text] [Related]

  • 11. Sinako, a study on HIV competent households in South Africa: a cluster-randomised controlled trial protocol.
    Masquillier C, Knight L, Campbell L, Sematlane N, Delport A, Dube T, Wouters E.
    Trials; 2020 Feb 10; 21(1):154. PubMed ID: 32041656
    [Abstract] [Full Text] [Related]

  • 12. Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda.
    Alhassan Y, Twimukye A, Malaba T, Orrell C, Myer L, Waitt C, Lamorde M, Kambugu A, Reynolds H, Khoo S, Taegtmeyer M.
    BMC Health Serv Res; 2020 Aug 01; 20(1):705. PubMed ID: 32738918
    [Abstract] [Full Text] [Related]

  • 13. A qualitative exploration of facilitators and barriers of adherence to time-restricted eating.
    O'Connor SG, Boyd P, Bailey CP, Nebeling L, Reedy J, Czajkowski SM, Shams-White MM.
    Appetite; 2022 Nov 01; 178():106266. PubMed ID: 35934114
    [Abstract] [Full Text] [Related]

  • 14. Perceptions of body size, obesity threat and the willingness to lose weight among black South African adults: a qualitative study.
    Okop KJ, Mukumbang FC, Mathole T, Levitt N, Puoane T.
    BMC Public Health; 2016 Apr 29; 16():365. PubMed ID: 27129700
    [Abstract] [Full Text] [Related]

  • 15. Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    Hauser A, Kusejko K, Johnson LF, Günthard HF, Riou J, Wandeler G, Egger M, Kouyos RD.
    PLoS Med; 2020 Dec 29; 17(12):e1003397. PubMed ID: 33315863
    [Abstract] [Full Text] [Related]

  • 16. Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
    Quist JS, Pedersen HE, Jensen MM, Clemmensen KKB, Bjerre N, Ekblond TS, Uldal S, Størling J, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Nyeland ME, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Blond MB, Færch K.
    Lancet Healthy Longev; 2024 May 29; 5(5):e314-e325. PubMed ID: 38588687
    [Abstract] [Full Text] [Related]

  • 17. Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study.
    Madlala HP, Myer L, Jao J, Geffen H, Matjila M, Fisher A, Meyer D, Werner EF, Petro G, Cu-Uvin S, McGarvey ST, Bengtson AM.
    J Int AIDS Soc; 2024 Jun 29; 27(6):e26313. PubMed ID: 38926935
    [Abstract] [Full Text] [Related]

  • 18. Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort study.
    Nightingale S, Dreyer AJ, Thomas KGF, van Zyl G, Decloedt E, Naude PJW, Orrell C, Sinxadi P, Winston A, Khoo S, Joska JA.
    Lancet HIV; 2024 Oct 29; 11(10):e680-e689. PubMed ID: 39284338
    [Abstract] [Full Text] [Related]

  • 19. Acceptability and feasibility of a planned preconception weight loss intervention in women with long-acting reversible contraception: the Plan-it mixed-methods study.
    Channon S, Coulman E, Cannings-John R, Henley J, Lau M, Lugg-Widger F, Strange H, Davies F, Sanders J, Scherf C, Couzens Z, Morantz L.
    Health Technol Assess; 2023 Jan 29; 27(1):1-224. PubMed ID: 36688498
    [Abstract] [Full Text] [Related]

  • 20. Watching, keeping and squeezing time to lose weight: Implications of time-restricted eating in daily life.
    Bjerre N, Holm L, Quist JS, Færch K, Hempler NF.
    Appetite; 2021 Jun 01; 161():105138. PubMed ID: 33524440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.